Aurora Financial JournalObserve Medical ASA (OBSRV.OL)
Oslo Børs · Financial statements, TTM figures and earnings dates
In fiscal year 2023 (ended December 31, 2023), Observe Medical ASA reported revenue of NOK 27.9M and net income of −NOK 60.4M. Annual financial statements are available for fiscal years 2020 to 2023, taken from the company's ESEF annual reports (IFRS).
Open interactive financials →Key financials
| NOK | FY2023 2023-12-31 | FY2022 2022-12-31 | FY2021 2021-12-31 | FY2020 2020-12-31 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | NOK 27.9M | NOK 19.5M | NOK 24.0M | NOK 3.0M |
| Gross profit | NOK 9.3M | NOK 5.2M | NOK 9.5M | NOK 986.0K |
| Operating income | −NOK 51.3M | −NOK 59.1M | −NOK 36.5M | −NOK 28.1M |
| Net income | −NOK 60.4M | −NOK 50.8M | −NOK 26.3M | −NOK 36.9M |
| Diluted EPS | −NOK 1.05 | −NOK 1.08 | −NOK 1.34 | −NOK 2.22 |
| Cash flow | ||||
| Operating cash flow | −NOK 24.5M | −NOK 51.3M | −NOK 22.1M | −NOK 21.6M |
| Balance sheet | ||||
| Cash and equivalents | NOK 13.7M | NOK 13.6M | NOK 2.9M | NOK 18.9M |
| Total assets | NOK 253.5M | NOK 215.8M | NOK 71.7M | NOK 87.7M |
| Total liabilities | NOK 137.9M | NOK 77.5M | NOK 85.9M | NOK 67.4M |
| Total debt | NOK 54.5M | NOK 45.7M | NOK 48.0M | NOK 34.8M |
| Shareholders' equity | NOK 115.6M | NOK 138.3M | −NOK 14.1M | NOK 20.3M |
TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in NOK as reported; per-share data adjusted for stock splits.
Annual reports
More on the interactive page
The full OBSRV.OL page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.
Open OBSRV.OL financials →